← Back

Ningbo Tianyi Medical Appliance Co. Ltd.

Ningbo Tianyi Medical Appliance Co., Ltd. develops, produces, and sells medical polymer consumables and other medical devices for blood purification and ward nursing. Its offerings include hemodialysis products such as blood tubing systems, hemofiltration tubing, and dialysis concentrates, as well as CRRT consumables like customized tubing and plasma adsorbers. The company also provides single-use oxygen delivery and infusion products, along with technical, sterilization, and product development services. Incorporated in 1998, it is headquartered in Ningbo, China, and serves markets in China, Hong Kong, Macao, Taiwan, and internationally.

Price · split & dividend adjusted
News & notes moving 301097.CS
European UnionChina
301097.CS▲

Tianyi Medical's Hemodialysis Dry Powder Receives EU MDR Certification

Tianyi Medical announced on September 23 that it has recently received the European Union Medical Device Regulation, or MDR, certification for its hemodialysis dry powder. The company stated that obtaining the EU MDR certificate demonstrates it has established a quality management system aligned with the regulation, that the product complies with current EU medical device regulatory requirements, and that it is qualified to enter the EU market as well as other countries and regions that recognize EU MDR certification. In the first half of 2026, Tianyi Medical achieved revenue of 338 million yuan and net profit attributable to the parent company of 16.12 million yuan.
Ningbo Tianyi… ▲
301097.CS · Regulation · Positive Tianyi Medical received EU MDR certification for its hemodialysis dry powder, qualifying it to enter the EU and other MDR-recognizing markets.
Read original ↗
财中社·12dRead more →
301097.CS▼2

Tianyi Medical Releases 2026 Interim Report with Net Profit of 16.1177 Million Yuan

Tianyi Medical released its 2026 interim report, with net profit attributable to the parent company of 16.1177 million yuan. The company's total operating revenue was 338 million yuan, and net cash flow from operating activities was negative 9.6654 million yuan, a year-on-year decrease of 130.32%. The latest asset-liability ratio was 53.35%, up 4.70 percentage points from the previous quarter and up 15.24 percentage points from the same period last year. The company's latest gross margin was 46.78%, down 1.14 percentage points from the previous quarter. The latest return on equity was 1.58%, and diluted earnings per share was 0.27 yuan. The company had 4,566 shareholders, and the top ten shareholders held 61.2667 million shares, accounting for 75.07% of the total share capital.
Ningbo Tianyi… ▼
301097.CS · Capital · Negative Net profit of 16.1177 million yuan with negative operating cash flow and rising debt ratio.
Read original ↗
Jiemian·45dRead more →
301097.CS▲2

Tianyi Medical’s Thai Subsidiary Obtains Import Filing Certificate for Sodium Citrate Anticoagulant Solution

Tianyi Medical announced that its wholly-owned subsidiary, Thailand Tianyi, has recently obtained the Medical Device Import Detail Filing Acceptance Certificate for sodium citrate anticoagulant solution from the Thai Ministry of Public Health. This product is indicated for patients undergoing continuous renal replacement therapy who require a sodium citrate anticoagulation regimen, particularly those at high risk of bleeding or with heparin-induced thrombocytopenia.
Ningbo Tianyi… ▲
301097.CS · Regulation · Positive Thai subsidiary obtained import filing certificate for sodium citrate anticoagulant solution, enabling market access.
Read original ↗
CLS·70dRead more →
© 2026 MarketDXAsset